Gastrointestinal Drugs-Global Market Status and Trend Report 2013-2023
Report Summary
Gastrointestinal Drugs-Global Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Gastrointestinal Drugs industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Regional Market Size of Gastrointestinal Drugs 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Gastrointestinal Drugs worldwide, with company and product introduction, position in the Gastrointestinal Drugs market
Market status and development trend of Gastrointestinal Drugs by types and applications
Cost and profit status of Gastrointestinal Drugs, and marketing status
Market growth drivers and challenges
The report segments the global Gastrointestinal Drugs market as:
Global Gastrointestinal Drugs Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America
Europe
China
Japan
Rest APAC
Latin America
Global Gastrointestinal Drugs Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Acid Neutralizers
Antidiarrheal and Laxatives
Antiemetic and Antinauseants
Anti-inflammatory Drugs
Biologics
Others
Global Gastrointestinal Drugs Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Gastrointestinal Drugs Market: Manufacturers Segment Analysis (Company and Product introduction, Gastrointestinal Drugs Sales Volume, Revenue, Price and Gross Margin):
Abbott Laboratories
Allergan
AstraZeneca
Bayer
Boehringer Ingelheim
GlaxoSmithKline
Janssen Biotech
Sanofi
Takeda Pharmaceutical
Valeant Pharmaceuticals
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Gastrointestinal Drugs-Global Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Gastrointestinal Drugs industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Regional Market Size of Gastrointestinal Drugs 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Gastrointestinal Drugs worldwide, with company and product introduction, position in the Gastrointestinal Drugs market
Market status and development trend of Gastrointestinal Drugs by types and applications
Cost and profit status of Gastrointestinal Drugs, and marketing status
Market growth drivers and challenges
The report segments the global Gastrointestinal Drugs market as:
Global Gastrointestinal Drugs Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America
Europe
China
Japan
Rest APAC
Latin America
Global Gastrointestinal Drugs Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Acid Neutralizers
Antidiarrheal and Laxatives
Antiemetic and Antinauseants
Anti-inflammatory Drugs
Biologics
Others
Global Gastrointestinal Drugs Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Gastrointestinal Drugs Market: Manufacturers Segment Analysis (Company and Product introduction, Gastrointestinal Drugs Sales Volume, Revenue, Price and Gross Margin):
Abbott Laboratories
Allergan
AstraZeneca
Bayer
Boehringer Ingelheim
GlaxoSmithKline
Janssen Biotech
Sanofi
Takeda Pharmaceutical
Valeant Pharmaceuticals
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF GASTROINTESTINAL DRUGS
1.1 Definition of Gastrointestinal Drugs in This Report
1.2 Commercial Types of Gastrointestinal Drugs
1.2.1 Acid Neutralizers
1.2.2 Antidiarrheal and Laxatives
1.2.3 Antiemetic and Antinauseants
1.2.4 Anti-inflammatory Drugs
1.2.5 Biologics
1.2.6 Others
1.3 Downstream Application of Gastrointestinal Drugs
1.3.1 Hospital Pharmacies
1.3.2 Retail Pharmacies
1.3.3 Online Pharmacies
1.4 Development History of Gastrointestinal Drugs
1.5 Market Status and Trend of Gastrointestinal Drugs 2013-2023
1.5.1 Global Gastrointestinal Drugs Market Status and Trend 2013-2023
1.5.2 Regional Gastrointestinal Drugs Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Gastrointestinal Drugs 2013-2017
2.2 Sales Market of Gastrointestinal Drugs by Regions
2.2.1 Sales Volume of Gastrointestinal Drugs by Regions
2.2.2 Sales Value of Gastrointestinal Drugs by Regions
2.3 Production Market of Gastrointestinal Drugs by Regions
2.4 Global Market Forecast of Gastrointestinal Drugs 2018-2023
2.4.1 Global Market Forecast of Gastrointestinal Drugs 2018-2023
2.4.2 Market Forecast of Gastrointestinal Drugs by Regions 2018-2023
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Gastrointestinal Drugs by Types
3.2 Sales Value of Gastrointestinal Drugs by Types
3.3 Market Forecast of Gastrointestinal Drugs by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Gastrointestinal Drugs by Downstream Industry
4.2 Global Market Forecast of Gastrointestinal Drugs by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Gastrointestinal Drugs Market Status by Countries
5.1.1 North America Gastrointestinal Drugs Sales by Countries (2013-2017)
5.1.2 North America Gastrointestinal Drugs Revenue by Countries (2013-2017)
5.1.3 United States Gastrointestinal Drugs Market Status (2013-2017)
5.1.4 Canada Gastrointestinal Drugs Market Status (2013-2017)
5.1.5 Mexico Gastrointestinal Drugs Market Status (2013-2017)
5.2 North America Gastrointestinal Drugs Market Status by Manufacturers
5.3 North America Gastrointestinal Drugs Market Status by Type (2013-2017)
5.3.1 North America Gastrointestinal Drugs Sales by Type (2013-2017)
5.3.2 North America Gastrointestinal Drugs Revenue by Type (2013-2017)
5.4 North America Gastrointestinal Drugs Market Status by Downstream Industry (2013-2017)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Gastrointestinal Drugs Market Status by Countries
6.1.1 Europe Gastrointestinal Drugs Sales by Countries (2013-2017)
6.1.2 Europe Gastrointestinal Drugs Revenue by Countries (2013-2017)
6.1.3 Germany Gastrointestinal Drugs Market Status (2013-2017)
6.1.4 UK Gastrointestinal Drugs Market Status (2013-2017)
6.1.5 France Gastrointestinal Drugs Market Status (2013-2017)
6.1.6 Italy Gastrointestinal Drugs Market Status (2013-2017)
6.1.7 Russia Gastrointestinal Drugs Market Status (2013-2017)
6.1.8 Spain Gastrointestinal Drugs Market Status (2013-2017)
6.1.9 Benelux Gastrointestinal Drugs Market Status (2013-2017)
6.2 Europe Gastrointestinal Drugs Market Status by Manufacturers
6.3 Europe Gastrointestinal Drugs Market Status by Type (2013-2017)
6.3.1 Europe Gastrointestinal Drugs Sales by Type (2013-2017)
6.3.2 Europe Gastrointestinal Drugs Revenue by Type (2013-2017)
6.4 Europe Gastrointestinal Drugs Market Status by Downstream Industry (2013-2017)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Gastrointestinal Drugs Market Status by Countries
7.1.1 Asia Pacific Gastrointestinal Drugs Sales by Countries (2013-2017)
7.1.2 Asia Pacific Gastrointestinal Drugs Revenue by Countries (2013-2017)
7.1.3 China Gastrointestinal Drugs Market Status (2013-2017)
7.1.4 Japan Gastrointestinal Drugs Market Status (2013-2017)
7.1.5 India Gastrointestinal Drugs Market Status (2013-2017)
7.1.6 Southeast Asia Gastrointestinal Drugs Market Status (2013-2017)
7.1.7 Australia Gastrointestinal Drugs Market Status (2013-2017)
7.2 Asia Pacific Gastrointestinal Drugs Market Status by Manufacturers
7.3 Asia Pacific Gastrointestinal Drugs Market Status by Type (2013-2017)
7.3.1 Asia Pacific Gastrointestinal Drugs Sales by Type (2013-2017)
7.3.2 Asia Pacific Gastrointestinal Drugs Revenue by Type (2013-2017)
7.4 Asia Pacific Gastrointestinal Drugs Market Status by Downstream Industry (2013-2017)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Gastrointestinal Drugs Market Status by Countries
8.1.1 Latin America Gastrointestinal Drugs Sales by Countries (2013-2017)
8.1.2 Latin America Gastrointestinal Drugs Revenue by Countries (2013-2017)
8.1.3 Brazil Gastrointestinal Drugs Market Status (2013-2017)
8.1.4 Argentina Gastrointestinal Drugs Market Status (2013-2017)
8.1.5 Colombia Gastrointestinal Drugs Market Status (2013-2017)
8.2 Latin America Gastrointestinal Drugs Market Status by Manufacturers
8.3 Latin America Gastrointestinal Drugs Market Status by Type (2013-2017)
8.3.1 Latin America Gastrointestinal Drugs Sales by Type (2013-2017)
8.3.2 Latin America Gastrointestinal Drugs Revenue by Type (2013-2017)
8.4 Latin America Gastrointestinal Drugs Market Status by Downstream Industry (2013-2017)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Gastrointestinal Drugs Market Status by Countries
9.1.1 Middle East and Africa Gastrointestinal Drugs Sales by Countries (2013-2017)
9.1.2 Middle East and Africa Gastrointestinal Drugs Revenue by Countries (2013-2017)
9.1.3 Middle East Gastrointestinal Drugs Market Status (2013-2017)
9.1.4 Africa Gastrointestinal Drugs Market Status (2013-2017)
9.2 Middle East and Africa Gastrointestinal Drugs Market Status by Manufacturers
9.3 Middle East and Africa Gastrointestinal Drugs Market Status by Type (2013-2017)
9.3.1 Middle East and Africa Gastrointestinal Drugs Sales by Type (2013-2017)
9.3.2 Middle East and Africa Gastrointestinal Drugs Revenue by Type (2013-2017)
9.4 Middle East and Africa Gastrointestinal Drugs Market Status by Downstream Industry (2013-2017)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF GASTROINTESTINAL DRUGS
10.1 Global Economy Situation and Trend Overview
10.2 Gastrointestinal Drugs Downstream Industry Situation and Trend Overview
CHAPTER 11 GASTROINTESTINAL DRUGS MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Gastrointestinal Drugs by Major Manufacturers
11.2 Production Value of Gastrointestinal Drugs by Major Manufacturers
11.3 Basic Information of Gastrointestinal Drugs by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Gastrointestinal Drugs Major Manufacturer
11.3.2 Employees and Revenue Level of Gastrointestinal Drugs Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 GASTROINTESTINAL DRUGS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 Abbott Laboratories
12.1.1 Company profile
12.1.2 Representative Gastrointestinal Drugs Product
12.1.3 Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin of Abbott Laboratories
12.2 Allergan
12.2.1 Company profile
12.2.2 Representative Gastrointestinal Drugs Product
12.2.3 Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin of Allergan
12.3 AstraZeneca
12.3.1 Company profile
12.3.2 Representative Gastrointestinal Drugs Product
12.3.3 Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin of AstraZeneca
12.4 Bayer
12.4.1 Company profile
12.4.2 Representative Gastrointestinal Drugs Product
12.4.3 Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin of Bayer
12.5 Boehringer Ingelheim
12.5.1 Company profile
12.5.2 Representative Gastrointestinal Drugs Product
12.5.3 Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin of Boehringer Ingelheim
12.6 GlaxoSmithKline
12.6.1 Company profile
12.6.2 Representative Gastrointestinal Drugs Product
12.6.3 Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin of GlaxoSmithKline
12.7 Janssen Biotech
12.7.1 Company profile
12.7.2 Representative Gastrointestinal Drugs Product
12.7.3 Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin of Janssen Biotech
12.8 Sanofi
12.8.1 Company profile
12.8.2 Representative Gastrointestinal Drugs Product
12.8.3 Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin of Sanofi
12.9 Takeda Pharmaceutical
12.9.1 Company profile
12.9.2 Representative Gastrointestinal Drugs Product
12.9.3 Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin of Takeda Pharmaceutical
12.10 Valeant Pharmaceuticals
12.10.1 Company profile
12.10.2 Representative Gastrointestinal Drugs Product
12.10.3 Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin of Valeant Pharmaceuticals
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF GASTROINTESTINAL DRUGS
13.1 Industry Chain of Gastrointestinal Drugs
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF GASTROINTESTINAL DRUGS
14.1 Cost Structure Analysis of Gastrointestinal Drugs
14.2 Raw Materials Cost Analysis of Gastrointestinal Drugs
14.3 Labor Cost Analysis of Gastrointestinal Drugs
14.4 Manufacturing Expenses Analysis of Gastrointestinal Drugs
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
1.1 Definition of Gastrointestinal Drugs in This Report
1.2 Commercial Types of Gastrointestinal Drugs
1.2.1 Acid Neutralizers
1.2.2 Antidiarrheal and Laxatives
1.2.3 Antiemetic and Antinauseants
1.2.4 Anti-inflammatory Drugs
1.2.5 Biologics
1.2.6 Others
1.3 Downstream Application of Gastrointestinal Drugs
1.3.1 Hospital Pharmacies
1.3.2 Retail Pharmacies
1.3.3 Online Pharmacies
1.4 Development History of Gastrointestinal Drugs
1.5 Market Status and Trend of Gastrointestinal Drugs 2013-2023
1.5.1 Global Gastrointestinal Drugs Market Status and Trend 2013-2023
1.5.2 Regional Gastrointestinal Drugs Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Gastrointestinal Drugs 2013-2017
2.2 Sales Market of Gastrointestinal Drugs by Regions
2.2.1 Sales Volume of Gastrointestinal Drugs by Regions
2.2.2 Sales Value of Gastrointestinal Drugs by Regions
2.3 Production Market of Gastrointestinal Drugs by Regions
2.4 Global Market Forecast of Gastrointestinal Drugs 2018-2023
2.4.1 Global Market Forecast of Gastrointestinal Drugs 2018-2023
2.4.2 Market Forecast of Gastrointestinal Drugs by Regions 2018-2023
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Gastrointestinal Drugs by Types
3.2 Sales Value of Gastrointestinal Drugs by Types
3.3 Market Forecast of Gastrointestinal Drugs by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Gastrointestinal Drugs by Downstream Industry
4.2 Global Market Forecast of Gastrointestinal Drugs by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Gastrointestinal Drugs Market Status by Countries
5.1.1 North America Gastrointestinal Drugs Sales by Countries (2013-2017)
5.1.2 North America Gastrointestinal Drugs Revenue by Countries (2013-2017)
5.1.3 United States Gastrointestinal Drugs Market Status (2013-2017)
5.1.4 Canada Gastrointestinal Drugs Market Status (2013-2017)
5.1.5 Mexico Gastrointestinal Drugs Market Status (2013-2017)
5.2 North America Gastrointestinal Drugs Market Status by Manufacturers
5.3 North America Gastrointestinal Drugs Market Status by Type (2013-2017)
5.3.1 North America Gastrointestinal Drugs Sales by Type (2013-2017)
5.3.2 North America Gastrointestinal Drugs Revenue by Type (2013-2017)
5.4 North America Gastrointestinal Drugs Market Status by Downstream Industry (2013-2017)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Gastrointestinal Drugs Market Status by Countries
6.1.1 Europe Gastrointestinal Drugs Sales by Countries (2013-2017)
6.1.2 Europe Gastrointestinal Drugs Revenue by Countries (2013-2017)
6.1.3 Germany Gastrointestinal Drugs Market Status (2013-2017)
6.1.4 UK Gastrointestinal Drugs Market Status (2013-2017)
6.1.5 France Gastrointestinal Drugs Market Status (2013-2017)
6.1.6 Italy Gastrointestinal Drugs Market Status (2013-2017)
6.1.7 Russia Gastrointestinal Drugs Market Status (2013-2017)
6.1.8 Spain Gastrointestinal Drugs Market Status (2013-2017)
6.1.9 Benelux Gastrointestinal Drugs Market Status (2013-2017)
6.2 Europe Gastrointestinal Drugs Market Status by Manufacturers
6.3 Europe Gastrointestinal Drugs Market Status by Type (2013-2017)
6.3.1 Europe Gastrointestinal Drugs Sales by Type (2013-2017)
6.3.2 Europe Gastrointestinal Drugs Revenue by Type (2013-2017)
6.4 Europe Gastrointestinal Drugs Market Status by Downstream Industry (2013-2017)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Gastrointestinal Drugs Market Status by Countries
7.1.1 Asia Pacific Gastrointestinal Drugs Sales by Countries (2013-2017)
7.1.2 Asia Pacific Gastrointestinal Drugs Revenue by Countries (2013-2017)
7.1.3 China Gastrointestinal Drugs Market Status (2013-2017)
7.1.4 Japan Gastrointestinal Drugs Market Status (2013-2017)
7.1.5 India Gastrointestinal Drugs Market Status (2013-2017)
7.1.6 Southeast Asia Gastrointestinal Drugs Market Status (2013-2017)
7.1.7 Australia Gastrointestinal Drugs Market Status (2013-2017)
7.2 Asia Pacific Gastrointestinal Drugs Market Status by Manufacturers
7.3 Asia Pacific Gastrointestinal Drugs Market Status by Type (2013-2017)
7.3.1 Asia Pacific Gastrointestinal Drugs Sales by Type (2013-2017)
7.3.2 Asia Pacific Gastrointestinal Drugs Revenue by Type (2013-2017)
7.4 Asia Pacific Gastrointestinal Drugs Market Status by Downstream Industry (2013-2017)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Gastrointestinal Drugs Market Status by Countries
8.1.1 Latin America Gastrointestinal Drugs Sales by Countries (2013-2017)
8.1.2 Latin America Gastrointestinal Drugs Revenue by Countries (2013-2017)
8.1.3 Brazil Gastrointestinal Drugs Market Status (2013-2017)
8.1.4 Argentina Gastrointestinal Drugs Market Status (2013-2017)
8.1.5 Colombia Gastrointestinal Drugs Market Status (2013-2017)
8.2 Latin America Gastrointestinal Drugs Market Status by Manufacturers
8.3 Latin America Gastrointestinal Drugs Market Status by Type (2013-2017)
8.3.1 Latin America Gastrointestinal Drugs Sales by Type (2013-2017)
8.3.2 Latin America Gastrointestinal Drugs Revenue by Type (2013-2017)
8.4 Latin America Gastrointestinal Drugs Market Status by Downstream Industry (2013-2017)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Gastrointestinal Drugs Market Status by Countries
9.1.1 Middle East and Africa Gastrointestinal Drugs Sales by Countries (2013-2017)
9.1.2 Middle East and Africa Gastrointestinal Drugs Revenue by Countries (2013-2017)
9.1.3 Middle East Gastrointestinal Drugs Market Status (2013-2017)
9.1.4 Africa Gastrointestinal Drugs Market Status (2013-2017)
9.2 Middle East and Africa Gastrointestinal Drugs Market Status by Manufacturers
9.3 Middle East and Africa Gastrointestinal Drugs Market Status by Type (2013-2017)
9.3.1 Middle East and Africa Gastrointestinal Drugs Sales by Type (2013-2017)
9.3.2 Middle East and Africa Gastrointestinal Drugs Revenue by Type (2013-2017)
9.4 Middle East and Africa Gastrointestinal Drugs Market Status by Downstream Industry (2013-2017)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF GASTROINTESTINAL DRUGS
10.1 Global Economy Situation and Trend Overview
10.2 Gastrointestinal Drugs Downstream Industry Situation and Trend Overview
CHAPTER 11 GASTROINTESTINAL DRUGS MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Gastrointestinal Drugs by Major Manufacturers
11.2 Production Value of Gastrointestinal Drugs by Major Manufacturers
11.3 Basic Information of Gastrointestinal Drugs by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Gastrointestinal Drugs Major Manufacturer
11.3.2 Employees and Revenue Level of Gastrointestinal Drugs Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 GASTROINTESTINAL DRUGS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 Abbott Laboratories
12.1.1 Company profile
12.1.2 Representative Gastrointestinal Drugs Product
12.1.3 Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin of Abbott Laboratories
12.2 Allergan
12.2.1 Company profile
12.2.2 Representative Gastrointestinal Drugs Product
12.2.3 Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin of Allergan
12.3 AstraZeneca
12.3.1 Company profile
12.3.2 Representative Gastrointestinal Drugs Product
12.3.3 Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin of AstraZeneca
12.4 Bayer
12.4.1 Company profile
12.4.2 Representative Gastrointestinal Drugs Product
12.4.3 Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin of Bayer
12.5 Boehringer Ingelheim
12.5.1 Company profile
12.5.2 Representative Gastrointestinal Drugs Product
12.5.3 Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin of Boehringer Ingelheim
12.6 GlaxoSmithKline
12.6.1 Company profile
12.6.2 Representative Gastrointestinal Drugs Product
12.6.3 Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin of GlaxoSmithKline
12.7 Janssen Biotech
12.7.1 Company profile
12.7.2 Representative Gastrointestinal Drugs Product
12.7.3 Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin of Janssen Biotech
12.8 Sanofi
12.8.1 Company profile
12.8.2 Representative Gastrointestinal Drugs Product
12.8.3 Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin of Sanofi
12.9 Takeda Pharmaceutical
12.9.1 Company profile
12.9.2 Representative Gastrointestinal Drugs Product
12.9.3 Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin of Takeda Pharmaceutical
12.10 Valeant Pharmaceuticals
12.10.1 Company profile
12.10.2 Representative Gastrointestinal Drugs Product
12.10.3 Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin of Valeant Pharmaceuticals
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF GASTROINTESTINAL DRUGS
13.1 Industry Chain of Gastrointestinal Drugs
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF GASTROINTESTINAL DRUGS
14.1 Cost Structure Analysis of Gastrointestinal Drugs
14.2 Raw Materials Cost Analysis of Gastrointestinal Drugs
14.3 Labor Cost Analysis of Gastrointestinal Drugs
14.4 Manufacturing Expenses Analysis of Gastrointestinal Drugs
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
